Document:

EX-10.1

 Exhibit 10.1 

WRIGHT MEDICAL GROUP N.V. 

PERFORMANCE INCENTIVE PLAN 

ARTICLE I. 
 OBJECTIVES;
DEFINITIONS 
 1.1 Objectives of this Plan. Further to the Company’s shareholder-approved Board of Directors Compensation
Policy and the shareholder-approved Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, the primary objectives of this Plan are to attract, retain, recognize, engage, motivate and reward Participants by providing them with the
opportunity to earn competitive compensation directly linked to the performance of the Company and its Related Entities, and, in the case of certain Participants, individual performance of the Participant. 

1.2 Definitions. The following capitalized terms used in this Plan shall have the respective meanings set forth in this Section: 

(a) “Award” shall mean a payment made under this Plan. 

(b) “Basis for Award Calculation” shall mean the notional gross base salary rate in effect as of March 1 of the
Performance Year (before deductions for taxes and benefits and any deferrals of salary pursuant to plans sponsored by the Company or any Related Entity), prorated to cover the period under consideration, plus any increases that may have been granted
during the Performance Year, prorated to cover the period under consideration. All other compensatory incentives, premiums, bonuses or payments of any kind, including without limitation stock-based compensation, auto allowances, housing allowances,
relocation allowances, shall be excluded from the Basis for Award Calculation. 
 (c) “Board” shall mean the Board of
Directors of the Company. 
 (d) “Code” shall mean the United States Internal Revenue Code of 1986, as amended, or any
successor thereto. 
 (e) “Committee” shall mean the Compensation Committee of the Board or any other committee appointed
by the Board which is composed solely of “independent directors” within the meaning of the listing standards set forth by the NASDAQ Global Select Market and “outside directors” as defined under Section 162(m)(4)(c)(i) of
the Code and the regulations promulgated thereunder; provided, however, that with respect to any Award made to an Executive Director Participant, the term “Committee” shall mean the non-executive directors of the Company. 

(f) “Company” shall mean Wright Medical Group N.V., a public limited company (naamloze vennootschap) incorporated
under the laws of the Netherlands, and its successors and assigns. 
 (g) “Disability” shall mean the complete and
permanent inability by reason of illness or accident to perform the duties of the occupation at which a Participant was employed 

 
or served when such disability commenced, as determined by the Committee based upon medical evidence acceptable to it; provided, however, that if payment of an Award subject to Section 409A
of the Code is to be accelerated solely as a result of a Participant’s disability, disability shall have the meaning set forth in Section 409A of the Code. 

(h) “Executive Director Participant” shall mean any Participant who has been appointed by the general meeting of shareholders
of the Company and serves as an executive director of the Company. 
 (i) “Executive Officer Participant” shall mean any
Participant who is an “executive officer” of the Company within the meaning of Rule 3b-7 under the United States Securities Exchange Act of 1934, as amended. 

(j) “Fair Market Value” on a given date shall mean (i) if the Shares are listed on a national securities exchange, the
closing price of a Share reported as having occurred on the primary exchange with which the Shares are listed and traded on the date prior to such date, or, if there is no such sale on that date, then on the last preceding date on which such a sale
was reported; (ii) if the Shares are not listed on any national securities exchange but are traded or quoted on an automated quotation system, the closing price of a Share reported on the date prior to such date, or, if there is no such sale on
that date, then on the last preceding date on which a sale was reported; or (iii) if the Shares are not listed on a national securities exchange nor traded or quoted on an automated quotation system, the amount determined pursuant to one of the
methods set forth in Treas. Reg. § 1.409A-1(b)(5)(iv)(B)(2), as elected by the Committee. 
 (k) “Participant” shall
mean a regular full-time or part-time employee of the Company or a Related Entity who is eligible and designated by the Committee to participate in this Plan as set forth in Section 2.2 of this Plan. 

(l) “Performance Period” shall mean the period for which performance under this Plan is calculated, which unless otherwise
indicated by the Committee, shall be the Performance Year. 
 (m) “Performance Year” shall mean the Company’s fiscal
year, beginning on the first day of such fiscal year and ending on the last day of such fiscal year. 
 (n) “Plan” shall
mean this Wright Medical Group N.V. Performance Incentive Plan, as set forth herein and as may be amended and/or restated from time to time. 

(o) “Related Entity” shall mean, when referring to a subsidiary, any business entity (other than the Company) which is in an
unbroken chain of entities ending with the Company, if stock or voting interests possessing 50% or more of the total combined voting power of all classes of stock or other ownership interests of each of the entities other than the Company is owned
by one of the other entities in such chain and, when referring to a parent entity, the term “Related Entity” shall mean any entity in an unbroken chain of entities ending with the Company if each of the entities other than the Company owns
stock or other ownership interests possessing 50% or more of the total combined voting power of all classes of stock (or other ownership interests) in one of the other entities in such chain. 

  
 2 

 (p) “Shares” shall mean the ordinary shares, par value €0.03 per
share, of the Company. 
 ARTICLE II. 

ADMINISTRATION, ELIGIBILITY AND PARTICIPATION 

2.1 Administration. This Plan shall be administered and interpreted by the Committee. The Committee, in its sole discretion, may
delegate to the Company’s Chief Executive Officer or such other officer of the Company activities relating to Plan administration that are not required to be exercised by the Committee under applicable laws, rules and regulations and the
Committee’s formal written charter. Delegable activities include, but are not limited to, establishing any policies under this Plan, interpreting provisions of this Plan, determining eligibility to participate in this Plan subject to
Section 2.2 of this Plan, and approving any final payouts under this Plan that do not affect Executive Director Participants or Executive Officer Participants. Any determination made by the Committee and the Company’s Chief Executive
Officer or such other officer of the Company under this Plan shall be final and conclusive and binding upon all parties, including the Company and Participants. The Committee may employ such legal counsel, consultants and agents (including counsel
or agents who are employees of the Company or a Related Entity) as it may deem desirable for the administration of this Plan and may rely upon any opinion received from any such counsel or consultant or agent and any computation received from such
consultant or agent. All expenses incurred in the administration of this Plan, including, without limitation, for the engagement of any counsel, consultant or agent, shall be paid by the Company or a Related Entity. 

2.2 Eligibility. The Committee shall have the sole and absolute authority to designate Participants and shall designate Participants
for each Performance Period. The Committee may withdraw its approval for participation for a Participant at any time and in the event of such withdrawal, the employee concerned shall cease to be a Participant as of the date selected by the
Committee. At a minimum, a Participant shall be a regular, full-time or part-time, salaried, exempt United States employee of the Company or a Related Entity or an international and expatriate/inpatriate employee of the Company or a Related Entity
who is determined by the Committee to be eligible for participation and who meets all of the following criteria: 
 (a) Participant must be
employed by the Company or a Related Entity for at least two (2) months during the Performance Year with a hire date on or prior to November 1 of the Performance Year; 

(b) Participant must be an employee of the Company or a Related Entity on the last day of the Performance Year; 

(c) Participant must have met minimum job expectations and have performed satisfactorily, as determined by the Participant’s
manager/supervisor in conjunction with the Human Resources Department of the Company or a Related Entity; 
 (d) Participant must not have
been determined by the Committee to be in violation of any applicable law, rule or regulation or any of the Company’s policies and procedures, including without limitation the Wright Medical Group N.V. Code of Business Conduct; 

  
 3 

 (e) Participant must have completed all corporate compliance training mandated by the Company or
a Related Entity to be completed by such Participant prior to the end of the applicable Performance Period; and 
 (f) Participant must not
be covered by a sales compensation plan of the Company or any Related Entity. 
 2.3 Future Participation. Participation in the Plan
for one Performance Period by a Participant does not constitute a right of such Participant to continue or participate in succeeding Performance Periods. 

ARTICLE III. 
 SETTING
PERFORMANCE MEASURES AND GOALS 
 3.1 Performance Measures and Goals; Performance Periods. The Committee shall establish
performance measures and goals for each Performance Period in accordance with this Article III, and if applicable, the shareholder-approved Board of Directors Compensation Policy and the Wright Medical Group N.V. Amended and Restated 2010 Incentive
Plan, and shall determine the Performance Period(s) (e.g., quarterly or full-year) for which such performance goals shall be measured. For each Performance Period, each Participant shall have corporate performance goals determined pursuant to
Section 3.2 of this Plan, which shall be set forth in writing. In addition, certain Participants in the sole discretion of the Committee may have individual performance goals determined pursuant to Section 3.3 of this Plan, which shall be
set forth in writing. The Committee, or its designee, shall communicate the specific performance measures, performance goals, relative weighting of each measure, and achievement levels of each performance measure to each Participant as soon as
reasonably practicable after the establishment thereof. 
 3.2 Corporate Performance Goals. The corporate performance goals shall be
based upon performance measures in accordance with the shareholder-approved Board of Directors Compensation Policy and the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, in each case if applicable, such as sales revenue,
operating income before or after taxes, net income before or after taxes, net income before securities transactions, net or operating income excluding non-recurring charges, EBIT (earnings before interest and taxes), EBITDA (earnings before
interest, taxes, depreciation and amortization), adjusted EBITDA (EBITDA, as adjusted for stock-based compensation and special charges), return on assets, return on equity, return on capital, market share, earnings per share, cash flow, free cash
flow, revenue, revenue growth, expenses, stock price, dividends, total stockholder return, price/earnings ratio, market capitalization, book value, product quality, customer retention, unit sales, strategic business objectives or any other
performance measure deemed appropriate by the Committee in its sole discretion. The corporate performance goals may be measured either absolutely or by reference to an index or indices or the performance of one or more companies and determined
either on a consolidated basis or, as the context permits, on a divisional, subsidiary, line of business, project or geographical basis or in combinations thereof, and may subject to such adjustments, if any, as the Committee specifies. 

  
 4 

 3.3 Individual Performance Goals. Each Performance Period, each Participant subject to
individual performance goals shall be required to develop one or more written, measurable and specific Management By Objectives (MBOs), which must be agreed to and approved by the Participant and the Committee. MBOs must be agreed upon and approved
by a specific date set by the Committee. Participants who do not complete the individual performance goal setting process for a particular Performance Period by the deadlines established by the Committee may become ineligible to participate in this
Plan for such Performance Period. 
 3.4 Performance Measure Weightings. All corporate performance measures and MBOs for each
Performance Period shall be weighted for each Participant, with areas of critical importance or critical focus weighted most heavily. Weightings may differ from Participant to Participant and from Performance Period to Performance Period. 

3.5 Achievement Levels. Achievement levels from 1 to 5 shall be assigned for each corporate performance measure and MBO for each
Performance Period. Each achievement level shall equal the following performance level and percentage payout: 
  

									
	 Achievement

Level 1
	  	Achievement
Level 2	 	Achievement
Level 3	 	Achievement
Level 4	 	Achievement
Level 5
	“Below minimum” performance	  	“Below target”
performance	 	“Target”
 performance
	 	“Above target”
performance	 	“Maximum”
performance
	0% payout	  	50% payout	 	100% payout	 	150% payout	 	200% payout

 3.6 Corporate Performance Achievement Rating Calculations. As soon as reasonably practicable after the
appropriate financial and other data has been compiled after the end of each Performance Period, the Company’s Finance Department shall calculate the achievement rating for each corporate performance measure. 

3.7 Individual Performance Achievement Rating Calculations. As soon as reasonably practicable after the end of each Performance Period,
each Participant with MBOs for such Performance Period shall review his or her MBOs and results for such Performance Period with his or her direct manager to determine the achievement rating earned for each MBO. Each MBO achievement rating shall
then be combined in the light of the applicable weightings to calculate a Participant’s overall weighted individual performance achievement rating for his or her MBOs. 

3.8 Award Minimum Trigger or Funding Gate. The Committee, in its sole discretion, may (but is not required to) establish a minimum
trigger or threshold performance goal that must be met in order for there to be any Awards under this Plan or payouts for all or certain corporate or individual performance goals for all or certain Participants, in each case as determined by the
Committee, in its sole discretion. 

  
 5 

 ARTICLE IV. 

DETERMINATION AND CALCULATION OF AWARDS 

4.1 Incentive Targets. The Committee shall determine, in its sole discretion, incentive targets for all Participants based upon, among
other factors, their level of responsibility within the Company and Related Entities and impact on the Company’s business. These incentive targets shall represent the incentive (expressed as a percentage of a Participant’s notional gross
base salary rate) that a Participant is eligible to receive under this Plan, assuming “target” performance. A Participant’s incentive target shall not exceed 150% of a Participant’s notional gross base salary rate, assuming
“target” performance. If a Participant received a promotion during the Performance Period with a change in such Participant’s incentive target, the Award for the Participant will be prorated for the time spent at each incentive
target. 
 4.2 Calculation of Awards. As soon as reasonably practicable after the completion of a Performance Period and the
calculation of the achievement ratings for each corporate performance goal pursuant to Section 3.6 of this Plan and the overall weighted individual performance achievement rating for each Participant pursuant to Section 3.7 of this Plan
(if applicable), the Committee shall determine the Award, if any, to be paid to each Participant for such Performance Period pursuant to the terms of this Plan. In determining the Award to be made to each Participant for a Performance Period, no
payout shall be made with respect to any corporate performance goal with an achievement rating of less than 2.00 and no payout shall be made with respect to a Participant’s MBOs if the overall weighted individual performance achievement rating
for such Participant is less than 2.00. 
 4.3 Possible Award Adjustment in the Event of Quarterly Performance Periods. In the event
corporate performance goals are not achieved for any quarterly Performance Period but due to full year financial results, which if allocated equally amongst the four quarters would result in the achievement of one or more quarterly corporate
performance goals, the Committee may determine, in its sole discretion, that the payment of Awards for the entire Performance Year also include an additional payment equal to the amount of the quarterly Awards that are deemed achieved based on the
equal allocation of the full year financial results. 
 4.4 Discretionary Award Adjustments. The Committee, in its sole discretion,
may modify an Award if, in the Committee’s subjective judgment, the Participant has not been equitably treated by the mechanics of this Plan. In addition, the Committee, in its sole discretion, may reduce an Award if the Participant has been
placed on a performance improvement plan. 
 ARTICLE V. 

TIMING AND PAYMENT OF AWARDS 

5.1 Timing of Awards. Awards under this Plan shall be paid out to Participants as soon as reasonably practicable after the
Committee’s determination as to the amount of such Awards; provided, however, that the Committee has the discretion to pay out estimated Awards earlier based on estimated performance for a Performance Period and then provide a
“true-up” payment based on actual performance for the Performance Period; and provided, further, that Awards must be paid on or prior to March 15 of the calendar year following the Performance Year for which Awards are to be made.

  
 6 

 5.2 Manner of Payment of Awards. All Awards hereunder shall be paid in cash; provided,
however, that, if the Committee determines, in its sole discretion, a Participant may elect, at such time as may be specified by the Committee for the making of such elections, that such Participant’s Award be paid in Shares, in lieu of cash,
or a combination of cash and Shares. Any Shares issuable to a Participant under this Plan will be granted as an “Other Stock-Based Award” under the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, as may be amended from
time to time, or any subsequently adopted equity-based incentive plan of the Company. The number of Shares to be issued to a Participant upon such election shall be equal to (a) the amount of the Award, divided by (b) the Fair Market Value
of a Share as of immediately prior to the date of issuance of such Shares; provided, however, that the issuance of any Shares in accordance with this Section 5.2 shall be contingent on the availability of Shares under the Wright Medical Group
N.V. Amended and Restated 2010 Incentive Plan, as may be amended from time to time, or any subsequently adopted equity-based incentive plan of the Company, and shall otherwise be in accordance with the terms of the Wright Medical Group N.V. Amended
and Restated 2010 Incentive Plan, as may be amended from time to time, or any subsequently adopted equity-based incentive plan of the Company. 

5.3 Errors in Award Calculations or Payments. To the extent, the Committee should later determine that an Award was incorrectly paid or
calculated, the Participant shall return to the Company the amount of any such incorrect payment or the Company or Related Entity should pay the Participant any additional amount to correct the error, as applicable. 

5.4 Clawback and Recoupment of Awards. To the extent required or permitted by applicable laws, rules or regulations, securities
exchange listing requirements or any Company policy implementing the foregoing, the Company shall have the right, and shall take all actions necessary, to recover any Awards or amounts paid to any Participant under this Plan. Any recoupment of an
Award made with respect to a Participant may be in addition to any other remedies that may be available to the Company or any Related Entity under applicable law, including disciplinary actions up to and including termination of employment. 

ARTICLE VI. 
 EMPLOYMENT
STATUS CHANGES 
 6.1 New Hires. All Participants newly hired on or prior to November 1st of a Performance Year will have their Awards prorated for the period of participation in this Plan. 

6.2 Transfer. Participants who transfer within the Company or its Related Entities to or from another incentive plan or business unit
performance measures during the Performance Year will be eligible for an Award under this Plan on a prorated basis, provided that all eligibility requirements are met. Awards granted to such transferred Participants shall not be based upon
performance goals achieved under this Plan prior to the date of transfer. 
 6.3 Prorated Award. Provided that the performance goals
are achieved, an Award will be prorated, and paid, if a Participant meets all other eligibility requirements under Section 2.2 of this Plan and otherwise during the Performance Year but is not a regular, active Participant on the last day of
the Performance Year due to one of the following reasons: 
 (a) Participant leaves his or her position due to a Disability; or 

  
 7 

 (b) Participant dies during a Performance Year (the prorated Award, if any, will be paid to the
Participant’s estate); or 
 (c) Participant takes a military leave during the Performance Year. 

6.4 Termination of Employment. Unless otherwise determined by the Committee, a Participant shall not be entitled to any Award hereunder
with respect to a Performance Period in the event of the termination of the Participant’s employment with the Company and its Related Entities for any reason prior to the last day of the Performance Period. 

ARTICLE VII. 

MISCELLANEOUS MATTERS 
 7.1
Term of this Plan. This Plan shall become effective on such date as approved by the Board. This Plan shall remain in effect until terminated by the Board or the Committee. 

7.2 Amendment; Termination. The Board or the Committee, at any time and in its sole discretion, may amend, suspend, discontinue or
terminate this Plan or any portion of this Plan for any reason or no reason whatsoever. 
 7.3 Plan Discretion. All benefits payable
under this Plan are discretionary and no Participant shall have any right to payment under this Plan until actually paid. To the extent necessary with respect to a Performance Period, in order to avoid any undue windfall or hardship due to external
causes, the Committee may without the consent of any affected Participant, revise one or more of the performance goals, or otherwise make adjustments to Awards under the Plan to take into account any acquisition or disposition by the Company or any
Related Entity not planned for at the time the performance goals were established, any change in accounting principles or standards, or any extraordinary or non-recurring event or item, so as to equitably reflect such event or events, such that the
criteria for evaluating whether a performance goal has been achieved will be substantially the same (as determined by the Committee) following such event as prior to such event. 

7.4 Non-Funded, Unsecured Obligation. This Plan shall be unfunded. No provisions of this Plan shall require the Company or any Related
Entity, for the purpose of satisfying any obligations under this Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or otherwise to segregate any assets. Participants shall have no rights under
this Plan other than as unsecured general creditors of the Company. 
 7.5 Claim to Awards and Employment Rights. This document sets
forth the terms of this Plan and it is not intended to be a contract or employment agreement between any Participant and the Company or any Related Entity. Neither this Plan nor any action taken hereunder shall be construed as giving any Participant
any right to be retained in the employ or service of the Company or any Related Entity or constitute any contract or limit in any way the right of the Company or any Related Entity to change such person’s compensation or other benefits or to
terminate the employment or other service of such person with or without cause or notice. There is no obligation for uniformity of treatment of Participants. The terms and 

  
 8 

 
conditions of Awards and the Committee’s determinations and interpretations with respect thereto need not be the same with respect to each Participant (whether or not the Participants are
similarly situated). 
 7.6 No Liability of Committee Members. No member of the Committee shall be personally liable by reason of any
contract or other instrument executed by such member or on his or her behalf in his or her capacity as a member of the Committee nor for any mistake of judgment made in good faith, and the Company shall indemnify and hold harmless each member of the
Committee and each other employee, officer or director of the Company to whom any duty or power relating to the administration or interpretation of this Plan may be allocated or delegated, against any cost or expense (including counsel fees) or
liability (including any sum paid in settlement of a claim) arising out of any act or omission to act in connection with this Plan unless arising out of such person’s own fraud or willful bad faith; provided, however, that approval of the Board
shall be required for the payment of any amount in settlement of a claim against any such person. The foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the
Company’s articles of association, as a matter of law, or otherwise, or any power that the Company may have to indemnify them or hold them harmless. 

7.7 No Limitation on Corporate Actions. Nothing in this Plan shall be construed to prevent the Company or any of its Related Entities
from taking any corporate action which is deemed by it to be appropriate or in its best interest, whether or not such action would have any adverse effect on any Awards made under this Plan. No employee or other person shall have any claim against
the Company or any Related Entity as a result of any such action. 
 7.8 Non-Transferability. A Participant’s rights and
interest under this Plan, including amounts payable, may not be sold, assigned, donated, or transferred or otherwise disposed of, mortgaged, pledged or encumbered except, in the event of a Participant’s death, to a designated beneficiary to the
extent permitted by this Plan, or in the absence of such designation, by will or the laws of descent and distribution. 
 7.9 Tax
Withholding. Notwithstanding any other provision of this Plan, the Company or any Related Entity, as appropriate, shall have the right to deduct from all Awards of cash and/or Shares, valued at Fair Market Value on the date of payment, in an
amount the Company or any Related Entity, as appropriate, reasonably determines is necessary to satisfy all foreign, Federal, state or local taxes as required by law to be withheld with respect to such Awards and, in the case of Awards paid in
Shares, the Participant or other person receiving such Shares may be required to pay prior to delivery of such Shares, the amount of any such taxes which are required to be withheld, if any, with respect to such Shares. Subject to the disapproval of
the Committee in particular cases, Shares of equivalent Fair Market Value in payment of such withholding tax obligations may be accepted if the Participant of the Award elects to receive payment in such manner. 

7.10 Severability. If any provision of this Plan is held unenforceable, the remainder of this Plan shall continue in full force and
effect without regard to such unenforceable provision and shall be applied as though the unenforceable provision were not contained in this Plan. 

  
 9 

 7.11 Governing Law. Except in connection with matters of corporate governance and
authority (all of which shall be governed by the laws of the Company’s jurisdiction of organization), the validity, construction, interpretation, administration and effect of this Plan and any rules, regulations and actions relating to this
Plan shall be governed by and construed exclusively in accordance with the internal, substantive laws of the State of Delaware, United States, without regard to the conflict of law rules of the State of Delaware or any other jurisdiction. 

7.12 Other Compensation Plans. This Plan shall not affect any other compensation plan in effect for the Company, nor shall this Plan
preclude the Company from establishing any other forms of compensation for employees of the Company. 
 7.13 Deferrals. The
Committee, in its sole discretion, may permit a Participant to defer receipt of the payment of cash or Shares that otherwise would be delivered to a Participant under the Plan. Any such deferral elections shall be subject to such rules and
procedures as determined by the Committee, in its sole discretion, and shall be under a plan or arrangement consistent with the requirements of Section 409A of the Code. 

7.14 Compliance with Code Section 409A. The Company intends that this Plan and payments hereunder shall at all times be exempt
from the requirements of Section 409A of the Code and any and all regulations thereunder, including such regulations as may be promulgated after the effective date of this Plan and the Plan shall be interpreted and administered consistent with
such intention. If any payment under this Plan is or becomes subject to the requirements of Section 409A of the Code, the Plan and Award, as it relates to such payment, is intended to comply with the requirements of Section 409A and the
Plan shall be interpreted and administered consistent with such intention. 
 7.15 Code Section 162(m). With respect to a
Participant who is or may become a “Covered Employee,” as defined in Section 162(m) of the Code, and who has been granted a performance-based “Cash-Based Award” under the Wright Medical Group N.V. Amended and Restated 2010
Incentive Plan for the applicable Performance Period, it is intended that Awards under this Plan will be used by the Committee to determine the amount, if any, of a payout of such Cash-Based Award to such Participant, and will be deemed to have been
made under the terms of such Cash-Based Award and will not exceed the amount of, or be in addition to, any payout under such Cash-Based Awards. 

[Remainder of page intentionally left blank] 

  
 10 

 IN WITNESS WHEREOF, the undersigned has caused this Plan to be executed on behalf of the
Company effective as of October 1, 2015. 
  

			
	WRIGHT MEDICAL GROUP N.V.
		
	By:	 	 /s/ Robert J. Palmisano

		 	Robert J. Palmisano
		 	President and Chief Executive Officer

  
 11EX-10.2

 Exhibit 10.2 

FORM A - STANDARD NON-ISO GRANT 

WRIGHT MEDICAL GROUP N.V. 

AMENDED AND RESTATED 2010 INCENTIVE PLAN 

OPTION CERTIFICATE 
 Wright
Medical Group N.V., a public limited liability company organized under the laws of The Netherlands (the “Company”), in accordance with the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, as such plan may be amended from
time to time (the “Plan”), hereby grants to the individual named below, who shall be referred to as “Optionee”, an option (the “Option”) to purchase from the Company that number of shares of Stock as indicated below at
an exercise price per share equal to that amount as indicated below, which grant shall be subject to all of the terms and conditions of this Option Certificate, which includes the Terms and Conditions (the “Terms and Conditions”) and any
Addendum to the Terms and Conditions established pursuant to Section 19 of the Terms and Conditions (the “Addendum”), as well as the terms and conditions of the Plan. This grant has been made as of the grant date indicated below,
which shall be referred to as the “Grant Date”. This Option is not intended to satisfy the requirements of Section 422 of the Code and thus shall be a Non-ISO as that term is defined in the Plan. 

 

			
	Grant Number:	  	[                    ]
		
	Optionee:	  	[NAME]
		
	Grant Date:	  	[DATE]
		
	Total Number of Shares of Stock Subject to Option:	  	[            ] shares of Stock, subject to adjustment as provided in the Plan.
		
	Exercise Price Per Share:	  	[            ]
		
	Expiration Date:	  	No later than the ten (10) year anniversary of Grant Date, as provided in Section 2(b) of the Terms and Conditions.
		
	Vesting Schedule:	  	Except as otherwise provided in the Terms and Conditions, Optionee’s right to exercise this Option shall vest, on a cumulative basis, over a four-year period and as follows: (1) 25% of the shares of Stock subject to this Option
shall vest on the one-year anniversary of the Grant Date (the “Vesting Commencement Date”), and (2) the remaining 75% of such shares of Stock shall vest over a three-year period thereafter in 36 as nearly equal as possible monthly
installments, beginning one month after the Vesting Commencement Date (each such vesting date, a “Scheduled Vesting Date”).

 TERMS AND CONDITIONS 

1. Plan. This Option grant is subject to these Terms and Conditions and the Plan. If a determination is made that any provision of
these Terms and Conditions is inconsistent with the Plan, the Plan shall control. All of the capitalized terms used in these Terms and Conditions not otherwise defined herein shall have the same meaning as defined in the Plan. A copy of the Plan and
the U.S. prospectus for the Plan have been delivered to Optionee together with this Option Certificate. 
 2. Vesting and Option
Expiration. 
  

	 	(a)	General Rule. Except as otherwise provided under these Terms and Conditions, Optionee’s right under these Terms and Conditions to exercise this Option shall vest, on a cumulative basis, over a four
(4) year period, as described in more detail in the foregoing Vesting Schedule and as provided in Section 12 of the Plan. 

  

	 	(b)	Option Expiration Rules. 

  

	 	(1)	 Non-Vested Shares of Stock. If Optionee’s continuous employment or service relationship (including service as an employee or as a
consultant) with the Company terminates for any reason whatsoever while there are any non-vested shares of Stock subject to this Option under Section 2(a), then, except as provided in Section 12 of the Plan, this Option immediately upon
such termination of employment or service shall expire and shall have no further force or effect and be null and void with respect to such non-vested shares of Stock; provided however, that upon a Life Event occurring, the interest of Optionee to
this Option shall vest immediately as to a pro rata percentage of the non-vested shares of Stock subject to this Option and scheduled to vest on the next Scheduled Vesting Date, with such proration based on the number of days during which Optionee
was continuously employed by the Company or provided services to the Company beginning on the Grant Date, or if a Scheduled Vesting Date has occurred, the most recent Scheduled Vesting Date, and ending on the next applicable Scheduled Vesting Date,
multiplied by the number of shares of Stock subject to this Option which were scheduled to vest on the next applicable Scheduled Vesting Date. For purposes of these Terms and Conditions, a “Life Event” shall mean Optionee’s death,
Disability, or Qualified Retirement. For purposes of these Terms and Conditions, a “Qualified Retirement” shall occur upon Optionee’s voluntary resignation from the Company or any Affiliate that employs

  
 –2– 

	 	
Optionee, provided that on the date of Optionee’s voluntary resignation, Optionee is sixty-five (65) years or older and Optionee has been continuously employed by the Company or any
Affiliate that employees Optionee for five (5) or more years. 

  

	 	(2)	Vested Shares of Stock. Optionee’s right to exercise the vested portion of this Option shall expire no later than the ten (10) year anniversary of the Grant Date. However, if Optionee’s employment
or service relationship with the Company terminates before the ten (10) year anniversary of the Grant Date, Optionee’s right to exercise the vested portion of this Option shall expire and shall have no further force or effect and shall be
null and void: 

  

	 	(A)	on the date Optionee’s employment or service relationship terminates if Optionee’s employment or service relationship terminates due to actions constituting Cause or Adverse Action, 

 

	 	(B)	on the one (1) year anniversary of the date Optionee’s employment or service relationship terminates as a result of Optionee’s death or Disability, or 

 

	 	(C)	at the end of the three (3) month period which starts on the date Optionee’s employment or service relationship terminates if Optionee’s employment or service relationship terminates other than
(1) due to actions constituting Cause or Adverse Action or (2) as a result of Optionee’s death or Disability. 

  

	 	(c)	Special Rules. 

  

	 	(1)	Sale of Business Unit. The Committee, in connection with the sale of any Affiliate that employs the Optionee, division or other business unit of the Company, may, within the Committee’s sole discretion, take
any or all of the following actions if this Option or the rights under this Option will be adversely affected by such transaction: 

  

	 	(A)	accelerate the time Optionee’s right to exercise this Option will vest under Section 2(a), 

  

	 	(B)	provide for vesting after such sale or other disposition, or 

  
 –3– 

	 	(C)	extend the time at which this Option will expire (but not beyond the ten (10) year anniversary of the Grant Date). 

  

	 	(2)	Change in Control. If there is a Change in Control of the Company, this Option shall be subject to the provisions of Section 12 of the Plan with respect to such Change in Control. 

 

	 	(3)	Affiliates. For purposes of these Terms and Conditions, any reference to the Company shall include any Affiliate that employs the Optionee, and a transfer of Optionee’s employment or service relationship
between the Company and any Affiliate of the Company or between any Affiliates of the Company shall not be treated as a termination of employment or service relationship under the Plan or these Terms and Conditions. 

 

	 	(4)	Termination of Employment or Service Relationship. For purposes of these Terms and Conditions: 

  

	 	(A)	if Optionee’s employment with the Company terminates while a portion of the Option is unvested but Optionee at such time then becomes an independent consultant to the Company, Optionee shall continue to vest in the
unvested portion of the Option pursuant to Section 2(a) so long as Optionee continues to provide services to the Company; 

  

	 	(B)	if Optionee’s employment with the Company terminates but Optionee at such time then becomes an independent consultant to the Company, the termination of Optionee’s employment shall not result in the expiration
of the Option under Section 2(b)(1) or 2(b)(2); provided, Optionee’s right to exercise the vested portion of the Option shall expire no later than the ten (10) year anniversary of the Grant Date; and 

 

	 	(C)	Except in instances where Optionee becomes an independent consultant to the Company as provided in clauses (A) and (B) above, Optionee’s employment termination date shall mean the last day that Optionee
actively performs services in an employer-employee relationship for the Company, without regard to the reason for Optionee’s cessation of service and without regard to any advance notice period as may be otherwise provided under local law.

  
 –4– 

	 	(5)	Effect of Actions Constituting Agreement Breach, Cause or Adverse Action. If Optionee is determined by the Committee, acting in its sole discretion, to have breached, in any material respect, its employment,
consulting, confidentiality, non-compete, non-solicitation and/or assignment of inventions agreement with the Company or any Affiliate or to have taken any action that would constitute Cause or an Adverse Action during or within one (1) year
after the termination of Optionee’s employment or other service with the Company, irrespective of whether such breach or action or the Committee’s determination occurs before or after termination of Optionee’s employment or other
service with the Company and irrespective of whether or not Optionee was terminated as a result of such breach, Cause or Adverse Action, (i) all rights of Optionee under the Plan and these Terms and Conditions, whether vested or unvested, shall
terminate and be forfeited without notice of any kind, and (ii) the Committee in its sole discretion shall have the authority to rescind the exercise, vesting or issuance of, or payment in respect of, this Option and to require Optionee to pay
to the Company, within ten (10) days of receipt from the Company of notice of such rescission, any amount received or the amount of any gain realized as a result of such rescinded exercise, vesting, issuance or payment (including any dividends
paid or other distributions made with respect to any shares subject to this Option). The Company may defer the exercise of this Option for a period of up to six (6) months after receipt of Optionee’s written notice of exercise or the
issuance of share certificates upon the exercise of this Option for a period of up to six (6) months after the date of such exercise in order for the Committee to make any determination as to the existence of such a breach, Cause or an Adverse
Action. This Section 2(c)(5) shall not apply following a Change in Control. 

  

	 	(6)	 Clawback Policy. This Option and the shares of Stock issuable pursuant to this Option are subject to forfeiture or clawback by the Company to
the extent required and allowed by law, including the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the Sarbanes Oxley Act of 2002 and any implementing rules and regulations promulgated thereunder, and pursuant to any
forfeiture, recoupment, clawback or similar policy of the Company, as such laws, rules, regulations and policy may be in effect from time to time. By accepting the Option under this Option Certificate, Optionee agrees and consents to the

  
 –5– 

	 	
Company’s application, implementation and enforcement of (a) any clawback / recoupment policy and (b) any provision of applicable law relating to the cancellation, recoupment,
rescission or payback of compensation and expressly agrees that the Company may take such actions as are necessary to effectuate the recoupment policy (as applicable to Optionee) or applicable law without further consent or action being required by
Optionee. For purposes of the foregoing, Optionee expressly and explicitly authorizes the Company to issue instructions, on Optionee’s behalf, to any brokerage firm and/or third party administrator engaged by the Company to hold the
Optionee’s shares of Stock and other amounts acquired under the Plan to re-convey, transfer or otherwise return such shares of Stock and/or other amounts to the Company. To the extent that the terms of this Option Certificate and the clawback /
recoupment policy conflict, the terms of the clawback / recoupment policy shall prevail. 

  

	 	(7)	Fractional Shares of Stock. Optionee’s right to exercise this Option shall not include a right to exercise this Option to purchase a fractional share of Stock. If Optionee exercises this Option on any date
when this Option includes a fractional share of Stock, Optionee’s exercise right shall be rounded down to the nearest whole share of Stock and the fractional share shall be carried forward until that fractional share together with any other
fractional shares can be combined to equal a whole share of Stock or this Option expires. 

  

	 	(8)	EU Age Discrimination Rules. If Optionee is a local national of and is employed in a country that is a member of the European Union, the grant of the Option and these Terms and Conditions governing the Option are
intended to comply with the age discrimination provisions of the EU Equal Treatment Framework Directive, as implemented into local law (the “Age Discrimination Rules”). To the extent that a court or tribunal of competent jurisdiction
determines that any provision of these Terms and Conditions is invalid or unenforceable, in whole or in part, under the Age Discrimination Rules, the Company, in its sole discretion, shall have the power and authority to revise or strike such
provision to the minimum extent necessary to make it valid and enforceable to the full extent permitted under local law. 

  
 –6– 

 3. Method of Exercise of Option. 

 

	 	(a)	General Rule. Optionee may exercise this Option in whole or in part (to the extent this Option is otherwise exercisable under Section 2 with respect to vested shares of Stock) only in accordance with the
rules and procedures established from time to time by the Company for the exercise of an Option. The Exercise Price shall be paid at exercise in cash (including check, bank draft or money order); provided, however, that the Committee, in its sole
discretion, may allow such payments to be made, in whole or in part, (i) by a “net exercise” of the Option (as further described below); (ii) through cashless exercise procedure which is effected by an unrelated broker through a
sale of Stock in the open market; or (iii) by a combination of such methods. In the case of a “net exercise” of this Option, Optionee shall receive the number of shares of Stock underlying this Option (or portion thereof so exercised)
reduced by the number of shares of Stock equal to the aggregate Exercise Price of the Option (or portion thereof so exercised) divided by the Fair Market Value on the date of exercise (the “Reduced Shares of Stock”). In the event of a
“net exercise” of this Option, this Option (or portion thereof so exercised) to purchase the Reduced Shares of Stock shall be cancelled in exchange for the right to receive an amount (the “Redemption Amount”) equal to the Fair
Market Value of the Reduced Shares of Stock on the date of exercise. The Redemption Amount shall automatically be applied by the Company to satisfy the amount Optionee is required to pay to exercise the Option (or portion thereof so exercised).
Thereafter, Optionee shall receive the number of shares of Stock remaining after such Reduced Shares of Stock have been cancelled. Shares of Stock shall no longer be outstanding under this Option (and shall thereafter not be exercisable) following
the exercise of this Option (or portion thereof so exercised) to the extent of (i) shares cancelled to pay the Exercise Price of this Option under the “net exercise,” (ii) shares actually delivered to Optionee as a result of such
exercise and (iii) any shares withheld for purposes of tax withholding. 

  

	 	(b)	Except as otherwise provided in these Terms and Conditions, if Optionee resides in a country (or is employed in a country, if different) where the local foreign exchange rules and regulations either preclude the
remittance of currency out of the country for purposes of paying the Exercise Price, or requires the Company and/or Optionee to secure any legal or regulatory approvals, complete any legal or regulatory filings, or undertake any additional steps for
remitting currency out of the country, the Company may restrict the method of exercise to a form of cashless exercise or such other form(s) of exercise (as it determines in its sole discretion). 

  
 –7– 

	 	(c)	As a condition of the grant of this Option, Optionee agrees to repatriate all payments attributable to the Option in accordance with local foreign exchange rules and regulations in Optionee’s country of residence
(and country of employment, if different). In addition, Optionee agrees to take any and all actions, and consents to any and all actions taken by the Company and its Affiliates, as may be required to allow the Company and its Affiliates to comply
with local laws, rules and regulations in Optionee’s country of residence (and country of employment, if different). Finally, Optionee agrees to take any and all actions that may be required to comply with his or her personal legal and tax
obligations under local laws, rules and regulations in Optionee’s country of residence (and country of employment, if different). 

4. Income Tax and Social Insurance Contributions Withholding. 
  

	 	(a)	Regardless of any action the Company takes with respect to any or all income tax (including U.S. federal, state and local taxes and/or non-U.S. taxes), social insurance, payroll tax, payment on account or other
tax-related withholding (“Tax-Related Items”), Optionee acknowledges that the ultimate liability for all Tax-Related Items legally due by Optionee is and remains Optionee’s responsibility and that the Company: (i) makes no
representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, including the grant of the Option, the vesting of the Option, and the exercise of the Option; and (ii) does not commit
to structure the terms of the Option or any aspect of the Option to reduce or eliminate Optionee’s liability for Tax-Related Items. If Optionee becomes subject to taxation in more than one country between the Grant Date and the date of any
relevant taxable or tax withholding event, as applicable, Optionee acknowledges that the Company may be required to withhold or account for Tax-Related Items in more than one country. 

 

	 	(b)	 Prior to the delivery of shares of Stock upon the exercise of the Option, if Optionee’s country of residence (and the country of employment, if
different) requires withholding of Tax-Related Items, the Company: (i) shall withhold a sufficient number of whole shares of Stock otherwise issuable upon the exercise of the Option that have an aggregate Fair Market Value sufficient to pay the
minimum Tax-Related Items required to be withheld (in which case, the cash equivalent of such withheld shares of Stock shall be used to settle the withholding obligation); or (ii) shall withhold an amount from Optionee’s regular salary
and/or wages, or from any other amounts 

  
 –8– 

	 	
payable to Optionee. In cases where shares of Stock are withheld and the Fair Market Value of the number of whole shares of Stock withheld is greater than the minimum Tax-Related Items required
to be withheld, the Company shall make a cash payment to Optionee equal to the difference as soon as administratively practicable. In the event the withholding requirements are not satisfied through the withholding of shares of Stock or through
Optionee’s regular salary and/or wages or other amounts payable to Optionee, no shares of Stock will be issued to Optionee unless and until satisfactory arrangements (as determined by the Committee) have been made by Optionee with respect to
the payment of any Tax-Related Items which the Company determines, in its sole discretion, must be withheld or collected with respect to the Option. By accepting the grant of the Option, Optionee expressly consents to the withholding of shares of
Stock and/or the withholding of amounts from Optionee’s regular salary and/or wages, or other amounts payable to Optionee, as provided for hereunder. All other Tax-Related Items related to the Option and any shares of Stock acquired pursuant to
the exercise of the Option is Optionee’s sole responsibility. 

 5. Delivery and Other Laws. The Company shall
deliver appropriate and proper evidence of ownership of any shares of Stock purchased pursuant to the exercise of this Option as soon as practicable after such exercise to the extent such delivery is then permissible under applicable law, rule or
regulation, and such delivery shall discharge the Company of all of its duties and responsibilities with respect to this Option. 
 6.
Non-Transferable. The Option may not be assigned, transferred, pledged or hypothecated in any manner other than (a) by will or the laws of descent or distribution or (b) to a “family member” as provided in
Section 14.2 of the Plan. The person or persons, if any, to whom this Option is transferred shall be treated after Optionee’s death the same as Optionee under these Terms and Conditions. 

7. No Right to Continue Employment or Service. Neither the Plan, this Option, nor any related material shall give Optionee the right to
continue in employment by or perform services to the Company or any Affiliate or shall adversely affect the right of the Company or any Affiliate to terminate Optionee’s employment or service relationship with the Company or any Affiliate with
or without Cause at any time. 
 8. Shareholder Status. Optionee shall have no rights as a shareholder of the Company with respect to
any shares of Stock under this Option until such shares have been duly issued and delivered to Optionee, and no adjustment shall be made for dividends of any kind or description whatsoever or for distributions of rights of any kind or description
whatsoever respecting such shares of Stock except as expressly set forth in the Plan. 

  
 –9– 

 9. Venue. For purposes of litigating any dispute that arises under this Option or these
Terms and Conditions, the parties hereby submit to and consent to the jurisdiction of the State of Tennessee, agree that such litigation shall be conducted in the courts of Shelby County, Tennessee, or the federal courts for the United States
for the Western District of Tennessee. 
 10. Binding Effect. These Terms and Conditions shall be binding upon the Company and
Optionee and their respective heirs, executors, administrators and successors. 
 11. Headings and Sections. The headings contained
in these Terms and Conditions are for reference purposes only and shall not affect in any way the meaning or interpretation of these Terms and Conditions. All references to sections in these Terms and Conditions shall be to sections of these Terms
and Conditions unless otherwise expressly stated as part of such reference. 
 12. Nature of the Grant. In accepting this Option
grant, Optionee acknowledges that: 
  

	 	(a)	the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or terminated by the Company in its sole discretion at any time, unless otherwise provided in
the Plan or these Terms and Conditions; 

  

	 	(b)	the grant of this Option is voluntary and occasional and does not create any contractual or other right to receive future Option grants, or benefits in lieu of Option grants, even if Option grants have been granted
repeatedly in the past; 

  

	 	(c)	all decisions with respect to future Option grants, if any, will be at the sole discretion of the Company; 

  

	 	(d)	Optionee is voluntarily participating in the Plan; 

  

	 	(e)	the Option grant is not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments,
bonuses, long-service awards, pension or retirement benefits or similar payments and in no event shall be considered as compensation for, or relating in any way to, past services for the Company;

  

	 	(f)	in the event that Optionee is not an employee of the Company, the Option will not be interpreted to form an employment contract or relationship with the Company; 

  
 –10– 

	 	(g)	the future value of the underlying shares of Stock is unknown and cannot be predicted with certainty and if Optionee vests in the Option grant, exercises this Option in accordance with the terms of these Terms and
Conditions and is issued shares of Stock, the value of those shares may increase or decrease; 

  

	 	(h)	Neither the Company, nor any Affiliate of the Company shall be liable for any foreign exchange rate fluctuation between the local currency of Optionee’s country of residence and the U.S. dollar that may affect the
value of the Option or of any amounts due to Optionee pursuant to the settlement of the Option or the subsequent sale of any shares of Stock acquired upon settlement of the Option; 

 

	 	(i)	in consideration of the grant of this Option, no claim or entitlement to compensation or damages shall arise from termination of this Option or diminution in value of this Option or shares of Stock acquired upon
exercise of this Option resulting from termination of Optionee’s employment or service by the Company (for any reason whatsoever and whether or not in breach of local labor laws) and Optionee irrevocably releases the Company and its Affiliates
from any such claim that may arise; if, notwithstanding the foregoing, any such claim is found by a court of competent jurisdiction to have arisen, then, by acceptance of these Terms and Conditions, Optionee shall be deemed irrevocably to have
waived his or her entitlement to pursue such claim; 

  

	 	(j)	the Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding Optionee’s participation in the Plan, or Optionee’s purchase or sale of the underlying
shares of Stock; and 

  

	 	(k)	Optionee is hereby advised to consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan or this Option.

 13. Non-Negotiable Terms. The provisions of these Terms and Conditions are not negotiable, but Optionee may refuse
to accept this Option by notifying immediately in writing the Company’s Senior Vice President and General Counsel or the Company’s Senior Vice President, Human Resources. 

14. Data Privacy Consent. Pursuant to applicable personal data protection laws, the Company hereby notifies Optionee of the following
in relation to Optionee’s personal data and the collection, use, processing and transfer of such data in relation to the Company’s grant of the Option and Optionee’s participation in the Plan. The collection, use, processing and
transfer of Optionee’s personal data is necessary for the Company’s administration of the Plan and Optionee’s participation in the Plan. 

  
 –11– 

 
Optionee’s denial and/or objection to the collection, use, processing and transfer of personal data may affect Optionee’s participation in the Plan. As such, Optionee voluntarily
acknowledges and consents (where required under applicable law) to the collection, use, processing and transfer of personal data as described herein. 

The Company holds certain personal information about Optionee, including Optionee’s name, home address and telephone number, date of
birth, social security number or other employee identification number, salary, nationality, job title, any shares of Stock or directorships held in the Company, details of all equity awards or any other entitlement to shares of Stock awarded,
canceled, purchased, vested, unvested or outstanding in Optionee’s favor, for the purpose of managing and administering the Plan (“Data”). The Data may be provided by Optionee or collected, where lawful, from third parties, and the
Company will process the Data for the exclusive purpose of implementing, administering and managing Optionee’s participation in the Plan. The Data processing will take place through electronic and non-electronic means according to logics and
procedures strictly correlated to the purposes for which Data are collected and with confidentiality and security provisions as set forth by applicable laws and regulations in Optionee’s country of residence (and country of employment, if
different). Data processing operations will be performed minimizing the use of personal and identification data when such operations are unnecessary for the processing purposes sought. Data will be accessible within the Company’s organization
only by those persons requiring access for purposes of the implementation, administration and operation of the Plan and for Optionee’s participation in the Plan. 

The Company will transfer Data as necessary for the purpose of implementation, administration and management of Optionee’s participation
in the Plan, and the Company may further transfer Data to any third parties assisting the Company in the implementation, administration and management of the Plan. These recipients may be located in the European Economic Area, or elsewhere
throughout the world, such as the United States. Optionee hereby authorizes (where required under applicable law) them to receive, possess, use, retain and transfer the Data, in electronic or other form, for purposes of implementing, administering
and managing Optionee’s participation in the Plan, including any requisite transfer of such Data as may be required for the administration of the Plan and/or the subsequent holding of shares of Stock on Optionee’s behalf to a broker or
other third party with whom Optionee may elect to deposit any shares of Stock acquired pursuant to the Plan. 
 Optionee may, at any time,
exercise his or her rights provided under applicable personal data protection laws, which may include the right to (a) obtain confirmation as to the existence of the Data, (b) verify the content, origin and accuracy of the Data,
(c) request the integration, update, amendment, deletion, or blockage (for breach of applicable laws) of the Data, and (d) to oppose, for legal reasons, the collection, use, processing or transfer of the Data which is not necessary or
required for the implementation, administration and/or operation of the Plan and Optionee’s participation in the Plan. Optionee may seek to exercise these rights by contacting Optionee’s local HR manager or the Company’s Human
Resources Department. 

  
 –12– 

 15. Private Placement. If Optionee is resident and/or employed outside of the United
States, the grant of the Option is not intended to be a public offering of securities in Optionee’s country of residence (and country of employment, if different). The Company has not submitted any registration statement, prospectus or other
filing with the local securities authorities (unless otherwise required under local law), and the Option is not subject to the supervision of the local securities authorities. No employee of the Company is permitted to advise Optionee on whether
Optionee should purchase shares of Stock under the Plan. Investment in shares of Stock involves a degree of risk. Before deciding to purchase shares of Stock pursuant to the Option, Optionee should carefully consider all risk factors relevant to the
acquisition of shares of Stock under the Plan and should carefully review all of the materials related to the Option and the Plan. In addition, Optionee should consult with his or her personal investment advisor for professional investment
advice. 
 16. Insider Trading/Market Abuse Laws. Optionee’s country of residence may have insider trading and/or market
abuse laws that may affect the Optionee’s ability to acquire or sell shares of Stock under the Plan during such times Optionee is considered to have “inside information” (as defined in the laws in Optionee’s country of
residence). These laws may be the same or different from any Company insider trading policy. Optionee acknowledges that it is Optionee’s responsibility to be informed of and compliant with such regulations, and Optionee is advised to consult
with Optionee’s personal advisors for additional information. 
 17. Electronic Delivery. The Company may, in its sole
discretion, decide to deliver any documents related to the Option granted to Optionee under the Plan by electronic means. Optionee hereby consents to receive such documents by electronic delivery and agrees to participate in the Plan through an
on-line or electronic system established and maintained by the Company or a third party designated by the Company. 
 18. English
Language. If Optionee is resident and/or employed outside of the United States, Optionee acknowledges and agrees that it is Optionee’s express intent that these Terms and Conditions, the Plan and all other documents, notices and legal
proceedings entered into, given or instituted pursuant to the Option, be drawn up in English. If Optionee has received these Terms and Conditions, the Plan or any other documents related to the Option translated into a language other than English,
and if the meaning of the translated version is different from the English version, the meaning of the English version shall control. 
 19.
Addendum. Notwithstanding any provisions of these Terms and Conditions to the contrary, the Option shall be subject to any special terms and conditions for Optionee’s country of residence (and country of employment, if different), as are
set forth in the applicable Addendum to these Terms and Conditions. Further, if Optionee transfers residence and/or employment to another country reflected in an Addendum to these Terms and Conditions, the special terms and conditions for such
country will apply to Optionee to the extent the Company determines, in its sole 

  
 –13– 

 
discretion, that the application of such terms and conditions is necessary or advisable in order to comply with local laws, rules and regulations or to facilitate the operation and administration
of the Option and the Plan (or the Company may establish alternative terms and conditions as may be necessary or advisable to accommodate Optionee’s transfer). Any applicable Addendum shall constitute part of these Terms and Conditions. 

20. Additional Requirements. The Company reserves the right to impose other requirements on the Option, any payment made pursuant to
the Option, and Optionee’s participation in the Plan, to the extent the Company determines, in its sole discretion, that such other requirements are necessary or advisable in order to comply with local laws, rules and regulations or to
facilitate the operation and administration of the Option and the Plan. Such requirements may include (but are not limited to) requiring Optionee to sign any agreements or undertakings that may be necessary to accomplish the foregoing. 

[Remainder of page intentionally left blank] 

  
 –14– 

 WRIGHT MEDICAL GROUP N.V. AMENDED AND RESTATED 

2010 INCENTIVE PLAN 

ADDENDUM TO 
 THE TERMS
AND CONDITIONS 
 In addition to the provisions of the Wright Medical Group N.V. Amended and Restated 2010 Incentive Plan, as such plan may be amended
from time to time (the “Plan”), and the Option Certificate (the “Option Certificate”), the Option is subject to the following additional terms and conditions as set forth in this addendum to the Terms and Conditions to the extent
Optionee resides and/or is employed in one of the countries addressed herein (the “Addendum”). All defined terms as contained in this Addendum shall have the same meaning as set forth in the Plan and the Option Certificate. To the extent
Optionee transfers residence and/or employment to another country, the special terms and conditions for such country as reflected in this Addendum (if any) will apply to Optionee to the extent the Company determines, in its sole discretion, that the
application of such terms and conditions is necessary or advisable in order to comply with local laws, rules and regulations, or to facilitate the operation and administration of the Option and the Plan (or the Company may establish alternative
terms and conditions as may be necessary or advisable to accommodate Optionee’s transfer). 
 AUSTRALIA 

1. Option Conditioned on Satisfaction of Regulatory Obligations. If Optionee is (a) a director of an Affiliate incorporated in
Australia, or (b) a person who is a management-level executive of an Affiliate incorporated in Australia and who also is a director of an Affiliate incorporated outside of the Australia, the grant of the Option is conditioned upon satisfaction
of the shareholder approval provisions of section 200B of the Corporations Act 2001 (Cth) in Australia. 
 BELGIUM 

 

									
	Name:	 	  
	 		 	Number of Shares:	 	  

	Grant Date:	 	  
	 		 	Exercise Price:	 	  

 1. Acceptance of Option. In order for the Option to be subject to taxation at the time of grant,
Optionee must affirmatively accept the in writing within 60 days of the Grant Date specified above by signing below and returning this original executed Addendum to: 

James A. Lightman, Senior Vice President and General Counsel 

Wright Medical Group N.V. 
 1023 Cherry Road 

Memphis, TN 38117 
 E-mail: James.Lightman@wmt.com 

  
 –15– 

 Optionee hereby accepts the Option granted by the Company on the Grant Date. Optionee acknowledges that he or she
has been encouraged to discuss the acceptance of the Option and the applicable tax treatment with a financial and/or tax advisor, and that Optionee’s decision to accept the Option is made in full knowledge. 

 

							
	Optionee Signature:	 	  
	 		 	
	Optionee Printed Name:	 	  
	 		 	
	Date of Acceptance:	 	  
	 		 	

 If Optionee fails to affirmatively accept the Option in writing within 60 days of the Grant Date, the Option will not be
subject to taxation at the time of grant but instead will be subject to taxation on the date Optionee exercises the Option (or such other treatment as may apply under Belgian tax law at the time of exercise). 

2. Payment of Exercise Price Limited to Cash Payment. Notwithstanding anything to the contrary in the Terms and Conditions or the Plan,
Optionee shall be permitted to pay the Exercise Price only by means of a cash payment (and the net exercise method shall not be permitted). 

3. Undertaking for Qualifying Option. If Optionee is accepting the Option in writing within 60 days of the Grant Date and wishes to
have the Option subject to a lower valuation for Belgium tax purposes pursuant to the article 43, §6 of the Belgian law of 26 March 1999, Optionee may agree and undertake to (a) not exercise the Option before the end of the third
calendar year following the calendar year in which the Grant Date falls, and (b) not transfer the Option under any circumstances (except upon on rights Optionee’s heir might have in the Option upon Optionee’s death). If Optionee
wishes to make this undertaking, Optionee must sign below and return this executed Addendum to the address listed above. 
  

							
	Optionee Signature:	 	  
	 		 	
	Optionee Printed Name:	 	  
	 		 	

 BRAZIL 

1. Commercial Relationship. Optionee expressly recognizes that Optionee’s participation in the Plan and the Company’s grant of
the Option does not constitute an employment relationship between Optionee and the Company. Optionee has been granted the Option as a consequence of the commercial relationship between the Company and the local Affiliate in Brazil that employs the
Optionee, and the local Affiliate in Brazil is Optionee’s sole employer. Based on the foregoing, (a) Optionee expressly recognizes the Plan and the benefits Optionee may derive from participation in the Plan do not establish any rights
between Optionee and the local Affiliate in Brazil, (b) the Plan and the benefits Optionee may derive from participation in the Plan are not part of the employment conditions and/or benefits provided by the local Affiliate in Brazil, and
(c) any modifications or amendments of the Plan by the Company, or a termination of the Plan by the Company, shall not constitute a change or impairment of the terms and conditions of Optionee’s employment with the local Affiliate in
Brazil. 

  
 –16– 

 2. Extraordinary Item of Compensation. Optionee expressly recognizes and acknowledges that
Optionee’s participation in the Plan is a result of the discretionary and unilateral decision of the Company, as well as Optionee’s free and voluntary decision to participate in the Plan in accord with the terms and conditions of the Plan,
the Option Certificate, and this Addendum. As such, Optionee acknowledges and agrees that the Company may, in its sole discretion, amend and/or discontinue Optionee’s participation in the Plan at any time and without any liability. The value of
the Option is an extraordinary item of compensation outside the scope of Optionee’s employment contract, if any. The Option is not part of Optionee’s regular or expected compensation for purposes of calculating any severance, resignation,
redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits, or any similar payments, which are the exclusive obligations of the local Affiliate in Brazil. 

BY SIGNING BELOW, OPTIONEE ACKNOWLEDGES, UNDERSTANDS AND AGREES TO THE PROVISIONS OF THE TERMS AND CONDITIONS, THE PLAN AND THIS ADDENDUM. 

 

	
	  

	Signature
	
	  

	Printed Name
	
	  

	Date

 IMPORTANT NOTE: THIS ADDENDUM MUST BE SIGNED AND RETURNED TO THE LOCAL HR DEPARTMENT OF WRIGHT AS SOON AS REASONABLY POSSIBLE
BUT NO LATER THAN 10 DAYS AFTER THE GRANT DATE. 
 CANADA 

1. No Exercise by Using Previously Owned Shares. Notwithstanding any provision in the Terms and Conditions or the Plan to the contrary,
if Optionee is resident in Canada, Optionee may not pay the Exercise Price by tendering shares of Stock already owned by Optionee. 

  
 –17– 

 FRANCE 

1. English Language. Optionee acknowledges and agrees that it is Optionee’s express intent that the Terms and Conditions, the Plan
and all other documents, notices and legal proceedings entered into, given or instituted pursuant to the Option, be drawn up in English. If Optionee has received the Terms and Conditions, the Plan or any other documents related to the Option
translated into a language other than English, and if the meaning of the translated version is different than the English version, the English version will control. 

Langue Anglaise. Le Bénéficiaire reconnaît et accepte que c’est son intention expresse que les Termes et Conditions, le Plan et tous
autres documents exécutés, avis donnés et procédures judiciaires intentées dans le cadre de à l’Option soient rédigés en anglais. Si le Bénéficiaire a reçu les Termes
et Conditions, le Plan ou tous autres documents relatifs à l’Option dans une autre langue que l’anglais et si le sens de la version traduite est différent de la version anglaise, la version anglaise prévaudra. 

BY SIGNING BELOW, OPTIONEE ACKNOWLEDGES, UNDERSTANDS AND AGREES TO THE PROVISIONS OF THE TERMS AND CONDITIONS, THE PLAN AND THIS ADDENDUM. 

 

	
	  

	Signature
	
	  

	Printed Name
	
	  

	Date

 IMPORTANT NOTE: THIS ADDENDUM MUST BE SIGNED AND RETURNED TO THE LOCAL HR DEPARTMENT OF WRIGHT AS SOON AS REASONABLY POSSIBLE
BUT NO LATER THAN 10 DAYS AFTER THE GRANT DATE. 
 HONG KONG 

1. IMPORTANT NOTICE. WARNING: The contents of the Option Certificate, the Addendum, the Plan, and all other materials pertaining to the
Option and/or the Plan have not been reviewed by any regulatory authority in Hong Kong. Optionee is hereby advised to exercise caution in relation to the offer thereunder. If Optionee has any doubts about any of the contents of the aforesaid
materials, Optionee should obtain independent professional advice. 
 2. Nature of the Plan. The Company specifically intends that
the Plan will not be treated as an occupational retirement scheme for purposes of the Occupational 

  
 –18– 

 
Retirement Schemes Ordinance (“ORSO”). To the extent any court, tribunal or legal/regulatory body in Hong Kong determines that the Plan constitutes an occupational retirement scheme for
the purposes of ORSO, the grant of the Option shall be null and void. 
 3. Wages. The Option and the shares of Stock subject to the
Option do not form part of Optionee’s wages for the purposes of calculating any statutory or contractual payments under Hong Kong law. 
 ITALY

 1. Mandatory Cashless Exercise. Notwithstanding anything in Section 3(a) of the Terms and Conditions to the contrary,
Optionee may exercise the Option only by means of a cashless “sell-all” exercise unless the amendments to the Italian Financial Services Act, which became effective 13 November 2012, permit the acquisition of shares of Stock pursuant
to the exercise of the Option without the involvement of an authorized financial intermediary in Italy (in which case, the Optionee may utilize any method of exercise permitted under the Terms and Conditions). Under a cashless “sell all”
exercise, all of the shares of Stock issuable upon exercise of the Option will be sold and the sales proceeds (net from the payment of the Exercise Price and any taxes and social insurance contributions that are required to be withheld pursuant to
Section 4 of the Terms and Conditions) will be paid to Optionee in cash. 
 NETHERLANDS 

1. Waiver of Termination Rights. As a condition to the grant of the Option, Optionee hereby waives any and all rights to compensation or
damages as a result of the termination of Optionee’s employment with the Company or any reason whatsoever, insofar as those rights result or may result from (a) the loss or diminution in value of such rights or entitlements under the Plan,
or (b) Optionee ceasing to have rights under, or ceasing to be entitled to any awards under the Plan as a result of such termination. 
 SINGAPORE

 1. Securities Law Information. The grant of the Option is being made pursuant to the “Qualifying Person” exemption
under section 273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (the “Act”). The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore and is not regulated by any
financial supervisory authority pursuant to any legislation in Singapore. The Optionee should note that, as a result, the Option is subject to section 257 of the SFA and accordingly, the Plan, the Option Certificate, this Addendum and any
other document or material in connection with the grant of the Option and the acquisition of shares of Stock pursuant to the Option may not be circulated or distributed, nor may the Option be offered or sold, or be made the subject of an invitation
for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (a) to a qualifying person under Section 273(1)(f) of the Act or (b) otherwise pursuant to, and in accordance with the conditions of, any
other applicable provision of the Act. 

  
 –19– 

 UNITED KINGDOM 

1. Income Tax and Social Insurance Contribution Withholding. The following provisions shall replace Section 4 of the Terms and
Conditions: 
 (a) Regardless of any action the Company takes with respect to any or all income tax and primary Class 1 National Insurance
contributions, payroll tax or other tax-related withholding attributable to or payable in connection with or pursuant to the grant, vesting or exercise of the Option, or the release or assignment of the Option for consideration, or the receipt of
any other benefit in connection with the Option (“Tax-Related Items”), Optionee acknowledges that the ultimate liability for all Tax-Related Items legally due by Optionee is and remains Optionee’s responsibility and that the Company:
(i) makes no representations or undertakings regarding the treatment of any Tax-Related Items in connection with any aspect of the Option, including the grant of the Option, the vesting of the Option, and the exercise of the Option; and
(ii) does not commit to structure the terms of the Option or any aspect of the Option to reduce or eliminate Optionee’s liability for Tax-Related Items. 

(b) As a condition of settling the Option following the date of exercise, the Company shall be entitled to withhold and Optionee agrees to
pay, or make adequate arrangements satisfactory to the Company to satisfy, all obligations of the Company to account to HM Revenue & Customs (“HMRC”) for any Tax-Related Items. In this regard, Optionee authorizes the Company to
withhold all applicable Tax-Related Items legally payable by Optionee from any wages or other cash compensation paid to Optionee by the Company. Alternatively, or in addition, if permissible under local law, Optionee authorizes the Company, at its
discretion and pursuant to such procedures as it may specify from time to time, to satisfy the obligations with regard to all Tax-Related Items legally payable by Optionee by one or a combination of the following: (i) withholding otherwise
deliverable shares of Stock; (ii) arranging for the sale of shares of Stock otherwise deliverable to Optionee (on Optionee’s behalf and at Optionee’s direction pursuant to this authorization); or (iii) withholding from the
proceeds of the sale of any shares of Stock acquired upon the exercise of the Option. If the obligation for Tax-Related Items is satisfied by withholding a number of whole shares of Stock as described herein, Optionee shall be deemed to have been
issued the full number of whole shares of Stock issued in exercise of the Option, notwithstanding that a number of shares of Stock are held back solely for the purpose of paying the Tax-Related Items due as a result of any aspect of the Option. If,
by the date on which the event giving rise to the Tax-Related Items occurs (the “Chargeable Event”), Optionee has relocated to a country other than the United Kingdom, Optionee acknowledges that the Company may be required to withhold or
account for Tax-Related Items in more than one country, including the United Kingdom. Optionee also agrees that the Company may determine the amount of Tax-Related Items to be withheld and accounted for by reference to the maximum applicable rates,
without prejudice to any right which Optionee may have to recover any overpayment from the relevant tax authorities. 

  
 –20– 

 (c) Optionee shall pay to the Company any amount of Tax-Related Items that the Company may be
required to account to HMRC with respect to the Chargeable Event that cannot be satisfied by the means previously described. If payment or withholding is not made within 90 days after the end of the UK tax year in which the Chargeable Event occurs
or such other period specified in section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003 (the “Due Date”), Optionee agrees that the amount of any uncollected Tax-Related Items shall (assuming Optionee are not a director
or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), constitute a loan owed by Optionee to the Company, effective on the Due Date. Optionee agrees that the loan
will bear interest at the then-current HMRC Official Rate and it will be immediately due and repayable, and the Company may recover it at any time thereafter by any of the means referred to above. If any of the foregoing methods of collection are
not allowed under applicable laws or if Optionee fails to comply with Optionee’s obligations in connection with the Tax-Related Items as described in this section, the Company may refuse to deliver any shares of Stock otherwise payable in
exercise of the Option. 
 2. Exclusion of Claim. Optionee acknowledges and agrees that Optionee will have no entitlement to
compensation or damages in consequence of the termination of Optionee’s employment with the Company for any reason whatsoever and whether or not in breach of contract, insofar as such entitlement arises or may arise from Optionee’s ceasing
to have rights under or to be entitled to exercise the Option as a result of such termination, or from the loss or diminution in value of the Option. Upon the grant of the Option, Optionee shall be deemed to have irrevocably waived any such
entitlement. 

*        *        *       
 *        * 
  

			
	WRIGHT MEDICAL GROUP N.V.
		
	By:	 	  

	Name:	 	Robert J. Palmisano
	Title:	 	President and Chief Executive Officer

*        *        *       
 *        * 

  
 –21– 

 Optionee acknowledges receipt of a copy of the Plan, represents that he or she is familiar
with the terms and provisions thereof, and hereby accepts this Option subject to all of the terms and provisions hereof and thereof. Optionee has reviewed this Option Certificate and the Plan in their entirety, has had an opportunity to obtain the
advice of counsel and fully understands all provisions of this Option Certificate and the Plan. Optionee also acknowledges receipt of the U.S. prospectus for the Plan. 

 

							
	Dated:                     	 		 	Signed:	 	  

		 		 	Name:	 	  

		 		 	Address:	 	  

		 		 	  

		 		 	  

  
 –22–

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]